标题:A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies
作者:Jing, Xiaoshu; Jin, Kang
作者机构:[Jin, Kang] Shandong Univ, Sch Pharm, Dept Med Chem, 44 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; [Jing, Xiaoshu] Shandong Univ, Sha 更多
通讯作者:Jin, K
通讯作者地址:[Jin, K]Shandong Univ, Sch Pharm, Dept Med Chem, 44 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
来源:MEDICINAL RESEARCH REVIEWS
出版年:2020
卷:40
期:2
页码:753-810
DOI:10.1002/med.21639
关键词:bioactivities; cyclic peptides; cyclization; drug discovery;; modification
摘要:As a versatile therapeutic modality, peptides attract much attention because of their great binding affinity, low toxicity, and the capability of targeting traditionally "undruggable" protein surfaces. However, the deficiency of cell permeability and metabolic stability always limits the success of in vitro bioactive peptides as drug candidates. Peptide macrocyclization is one of the most established strategies to overcome these limitations. Over the past decades, more than 40 cyclic peptide drugs have been clinically approved, the vast majority of which are derived from natural products. The de novo discovered cyclic peptides on the basis of rational design and in vitro evolution, have also enabled the binding with targets for which nature provides no solutions. The current review summarizes different classes of cyclic peptides with diverse biological activities, and presents an overview of various approaches to develop cyclic peptide-based drug candidates, drawing upon series of examples to illustrate each strategy.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074015980&doi=10.1002%2fmed.21639&partnerID=40&md5=d75655c2fe7634c28ba8226206457e58
TOP